|
Placebo tablet Clinical Trials
3 actively recruiting trials across 3 locations
▼ -1 trial since May 2026
Also known as: Placebo for MK-1242
Pipeline
Early 1: 1Phase 2: 1Phase 2/3: 1
Top Sponsors
- University of Minnesota1
- Merck Sharp & Dohme LLC1
- Mayo Clinic1
Indications
- Heart Disease3
- Fontan Circulation1
- Left Ventricular Systolic Dysfunction1
- Single Ventricle Heart Disease1
- HFpEF - Heart Failure With Preserved Ejection Fraction1
Los Angeles, California1 trial
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
The Regents of the University of California - Los Angeles (UCLA Pediatrics) ( Site 0002)
Phase 2/3
Minneapolis, Minnesota1 trial
Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure
University of Minnesota
Early 1
Rochester, Minnesota1 trial
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.